Upgrade to SI Premium - Free Trial

Gilead Sciences (GILD) PT Raised to $123 at RBC Capital

April 7, 2026 8:59 AM
RBC Capital analyst Brian Abrahams raised the price target on Gilead Sciences (NASDAQ: GILD) to $123.00 (from $118.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change